We evaluated the expression of MSTN and ActRIIB mRNA in muscle and adipose tissue in diet-induced obesity and insulin resistance in rats subjected to exercise. There was no difference in the expression of MSTN between exercised and sedentary high-fat fed rats in muscle after swimming training. The expression of ActRIIB mRNA in muscle was not significantly different among the groups. In BAT, MSTN mRNA expression was higher in exercised high-fat fed group (EHF) compared with sedentary high-fat fed group (SHF). ActRIIB mRNA expression in BAT was higher in EHF compared with SHF. In mesenteric fat, MSTN mRNA was lower in EHF compared with SHF and ActRIIB mRNA was lower in EHF compared with SHF. In conclusion, the results demonstrate that the expression of MSTN and ActRIIB mRNA changes in both adipose tissue and skeletal muscle in diet-induced obese and exercised rats and suggest the participation of MSTN in energy homeostasis.
Introduction
Myostatin (MSTN) or growth and differentiation factor 8 (GDF8) is a member of the transforming growth factor-␤ (TGF␤) superfamily and is characterized as a negative regulator of skeletal muscle mass in many species (McPherron and Lee, 1997) . MSTN circulates in plasma as an inactive complex, mostly bound to its pro-peptide, and is expressed mainly in muscle but also in adipose tissue (Allen et al., 2008; Hill et al., 2002) . Signaling of MSTN is similar to that of other TGF␤ family members such as TGF␤ and activins. In brief, upon ligand binding, the activin type II receptor kinase phosphorylates the activin type I receptor kinase. In the case of MSTN, type II and type I receptors are ActRIIB and ALK5, respectively (Lee et al., 2005; Rebbapragada et al., 2003) . Intracellularly, type I receptors activate members of the SMAD family signaling proteins, SMAD 2 and 3, which then translocate to the nucleus. In the nucleus, these signaling molecules positively or negatively regulate transcription Abbreviations: MSTN, myostatin; GDF8, growth and differentiation factor 8; ActRIIB, activin receptor IIB; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; BAT, brown adipose tissue; TGF␤, transforming growth factor-␤; ALK5, activin receptor-like kinases 5.
* of specific genes in association with diverse transcription factors (Welt et al., 2002) . In addition to the roles of MSTN on skeletal muscle growth, many studies have suggested the involvement of MSTN in the maintenance of metabolic homeostasis and in modulation of adipose tissue function and differentiation both in vivo and in vitro (Allen et al., 2008; Feldman et al., 2006; Guo et al., 2009; Kim et al., 2001; Zhao et al., 2005; Zimmers et al., 2002) . Introduction of MSTN null mutation into different obese strains resulted in reduction of fat accumulation and prevention of insulin resistance . Deletion of MSTN in mice produces skeletal muscle hypertrophy and, in contrast, reduction in total body fat (Lin et al., 2002; McPherron and Lee, 2002) and MSTN null mice fed high-fat diet are resistant to body fat gain (Hamrick et al., 2006) . In humans, it was recently demonstrated decreased expression of MSTN in muscle of first degree relatives of people with type 2 diabetes (Palsgaard et al., 2009 ). In addition, there are evidences that MSTN is regulated in response to diverse metabolic stimuli, such as physical exercise (Heinemeier et al., 2007; Hulmi et al., 2007; Matsakas et al., 2006; Matsakas et al., 2005; Raue et al., 2006) , which is linked to improved glucose homeostasis and enhanced insulin sensitivity.
The opposing effects of MSTN in these two important metabolic sites, muscle and adipose tissue, may suggest an interaction between them to produce metabolic effects by modulating MSTN. Open access under the Elsevier OA license.
Open access under the Elsevier OA license. Values are means ± S.E.M., n = 7-8 rats/group. *P < 0.05, sedentary high-fat diet group (SHF) vs. sedentary control group (SC); # P < 0.05, exercised control group (EC) vs. sedentary control group (SC).
In the present study, we evaluated the expression of MSTN and ActRIIB mRNA in muscle and adipose tissue in diet induced obesity and insulin resistance in rats subjected to exercise.
Methods

Animals and experimental groups
All procedures were approved by the Ethics Committee of the Federal University of São Carlos. Male Wistar rats (190 ± 18.4 g) were acclimated in individual cages under controlled temperature, humidity and lighting (12-h dark/light cycle) with free access to water and standard rodent chow. After 7 days, animals were randomly assigned to 2 groups, control rats (C) fed standard rodent chow and high-fat diet rats (HF) fed 60% of Kcal as fat (Research Diets, New Brunswick, NJ, USA). Animals and food intake were weighed daily. After 12 weeks, animals of both groups were randomly divided into 2 groups: sedentary C (SC) or exercised C (EC) and sedentary HF (SHF) or exercised HF (EHF).
Exercise protocol
Rats in the exercise groups (EC and EHF) were exercised by swimming for 1.5 h/day, 45 min at 9:00 AM and 45 min at 05:00 h PM, for 4 weeks. The swimming exercise was performed in plastic barrels (30 cm diameter) filled with water (50 cm deep) maintained at 32-36
• C and with a weight of 5% body weight (BW) attached to the tail of each rat. The protocol started with the animals swimming 30 min on the first day, gradually increasing so that in the forth day they could swim for 90 min. All animals were towel dried before returning to the cages. Sedentary groups were placed in shallow water for 5 min, towel dried and then returned to their cages at the same time as exercised groups. Both groups control and high-fat diet rats were able to carry out the exercise protocol similarly.
After the training period, rats were sacrificed by decapitation. Visceral white fat pads (mesenteric, retroperitoneal, epididymal), brown adipose tissue (BAT) and white gastrocnemius muscle were dissected, weighted, immediately frozen in liquid nitrogen and stored at −80
• C until analysis.
Glucose (GTT) and insulin (ITT) tolerance tests
GTT was performed after the acclimation period and at 3, 4, 8 and 12 weeks of dietary treatment and after exercise training, at the 16 th week. After overnight fast, unanesthetized rats were injected intraperitoneal (i.p.) with 1.5 g of 50% glucose solution per kg of body weight (BW). Blood samples were obtained from the tail vein before injection and at 30, 60, 90, and 120 min after glucose injection. ITT was performed after the acclimation period and at 8 and 12 weeks of dietary treatment. After overnight fast, unanesthetized rats were injected i.p. with human insulin 0.75U/kg BW. Blood samples were obtained from the tail vein before injection and at 15, 30, 60, and 90 min after insulin challenge. Blood glucose concentrations were measured by Accu-Check glucose meter (Roche Diagnostic, Indianapolis, USA).
RNA extraction and quantitative real-time PCR
Frozen samples of adipose tissues and white gastrocnemius muscles (100 mg) were homogenized on ice in TRIzol Reagent (Invitrogen Corporation, California, USA) according to the manufacture's instruction. The purity and yield of total RNA were determined by measuring the absorbance of aliquots at 260 and 280 nm. The integrity of RNA was checked on 2% agarose gel by inspecting the electrophoretic pattern of 28S and 18S ribosomal RNA. Total RNA (1 g) from each sample was treated with DNase I (Invitrogen Corporation California, USA) to remove contaminating genomic DNA, and reverse transcribed to synthesize cDNA by using M-MLV reverse transcriptase (Promega Corporation, Madison, WI, USA). For real-time PCR, 20 ng of cDNA and 0.5 M of each primer were used in 25 L volume system con- Values are means ± S.E.M., n = 7-8 rats per group. § P < 0.05, SC 12th week vs. 16th week. # P < 0.05, EC vs. SC at 16th week (post-exercise). * P < 0.05, SHF vs. SC at 12th week and at 16th week. ¶ P < 0.05, SHF 12th week vs. 16th week. & P < 0.05, EHF vs. SFH at 16th week. $ P < 0.05, EHF 12th week (pre-exercise) vs. 16th (post-exercise) week. SC, sedentary control group; EC, exercised control group; SHF, sedentary high-fat diet group; EHF, exercised high-fat diet group. taining SYBR Green PCR Master Mix (Applied Biosystems Inc., CA, USA). The primers sequences used were: myostatin (forward primer, 5 -CAA ACA GCC TGA ATC CAA CTT AG-3 ; reverse primer, 5 -CCG TGA GGG GGT AGC GAC AG-3 ); ActRIIB (forward primer, 5 -CAG GTT GGC ACC AGA CGG TAC-3 ; reverse primer, 5 -TCG ATG GTC ACG CAG AGC TGG-3 ) (Debieve et al., 2006; Garma et al., 2007) In addition, a standard curve of rats white gastrocnemius muscle cDNA was run in triplicate for every plate to produce a standard curve for quantification. All reactions were performed in quadruplicate. The relative amounts of RNAs were calculated using the comparative Ct method. The expression of all genes was normalized to glyceraldehydes-3-phosphate dehydrogenase (GAPDH) expression.
Data analysis
Statistical analysis was done by unpaired and paired Student's t tests and analysis of variance (ANOVA) one or two-way. Tukey's multiple comparisons test was used for post hoc analysis of between-group comparisons. Data are presented as means ± SEM. P < 0.05 was considered statistically significant.
Results
Body weight of high-fat diet fed animals was significantly higher than control animals beginning at the 5th week till the end of the training period (data not shown). At 16th week, both exercised control, and high-fat fed diet animals had significantly lower body weight compared to sedentary controls and high-fat fed diet animals, respectively. Post-exercise body weight at 16th week was significantly lower than pre-exercise body weight at 12th week in high-fat fed diet animals. However, pre-and post-exercise body weights of control animals were not different (Table 1) .
High-fat diet induced significantly increase in mesenteric, retroperitoneal and epididymal adipose tissue mass in sedentary high-fat fed diet animals compared to sedentary control animals. BAT fat pad weight increased in control exercised rats in comparison with sedentary controls. There was no other difference in fat pad weight after exercise in both control and high-fat diet fed animals (Fig. 1) .
Rats fed high-fat diet had significantly higher glycemia response to glucose injection than control rats since the third week of diet regimen ( Fig. 2A) . These animals had significantly higher glycemia response to insulin injection than control rats tested at both the eight and twelve week of diet regimen (Fig. 2B) . Post-exercise glycemia response to glucose injection was significantly lower than the pre-exercise test response in rats fed high-fat diet (Fig. 3) . No difference was observed between pre-and post-exercise glycemia response to glucose injection in control rats.
The MSTN mRNA expression was much lower in both white and brown adipose tissue relative to white gastrocnemuis muscle in control animals, as previously observed by Allen et al., 2008. There was no significant difference between white adipose tissues (mesenteric and epididymal fat depots) and brown adipose tissue, but MSTN mRNA levels were ∼10-200-fold lower in both adipose tissue stores than in white gastrocnemuis muscle (Fig. 4A) . Regarding ActRIIB mRNA expression, it was significantly higher in BAT than in white gastrocnemuis muscle (∼10-fold higher). No difference was observed between white and brown adipose tissue ActRIIB mRNA expression (Fig. 4B) .
In gatrocnemius muscle, swimming training resulted in a significant reduction of MSTN mRNA expression of exercised control rats compared to sedentary control rats but it did not alter the expression of MSTN in exercised compared to sedentary high-fat diet fed Fig. 3 . Area under the curve (AUC) analysis of glycemia profile in glucose tolerance test (GTT) pre-exercise (12th week) and post-exercise (16th week) training. Values are means ± S.E.M., n = 7-8 rats/group. *P < 0.05, exercised high-fat diet group pre-exercise (EHF pre-exercise) vs. exercised control group pre-exercise (EC preexercise); + P < 0.05, exercised high-fat diet group pre-exercise (EHF pre-exercise) vs. exercised high-fat diet group post-exercise (EHF post-exercise).
rats. The expression of ActRIIB mRNA was not significantly different among groups in gastrocnemius muscle (Fig. 5) .
The expression of MSTN mRNA in mesenteric fat tissue was significantly higher in sedentary high-fat diet fed rats than in sedentary control rats. In addition, MSTN mRNA levels decreased in mesenteric fat tissue in exercised high-fat fed group compared to sedentary high-fat fed group. The expression of ActRIIB mRNA decreased in both high-fat fed and control exercised rats compared to sedentary animals (Fig. 6) . MSTN mRNA levels were significantly lower in epididymal fat in sedentary high-fat diet fed rats compared to sedentary control rats. However, in epididymal fat the expression of ActRIIB mRNA was not significantly different among groups (Fig. 7) . In BAT, swimming training resulted in significant increase of MSTN mRNA in both exercised groups, control and high-fat diet fed rats. In this tissue, ActRIIB mRNA was significantly lower in control exercised and in sedentary high-fat diet fed rats compared to sedentary controls. However, ActRIIB mRNA was significantly higher in exercised high-fat fed rats compared to sedentary high-fat fed rats in BAT (Fig. 8) .
Discussion
The results show that the expression of MSTN and ActRIIB mRNA changes in both adipose tissue and skeletal muscle in diet-induced obese and exercised rats.
Obesity induced by high-fat diet was accompanied by decreased glucose tolerance as previously described (Chalkley et al., 2002; Woods et al., 2003) . Training increased insulin resistance in rats fed high-fat diet. It is well established that exercise is linked to enhanced insulin sensitivity in diet-induced obese rats by improving the insulin and AMP-activated protein kinase (AMPK) signaling pathway (Bruce and Hawley, 2004; Pauli et al., 2008; Yaspelkis et al., 2007) .
The expression of MSTN and ActRIIB mRNA differed among the three different adipose tissues studied. It is well established that different fat depots have different metabolic profiles, in special white and brown adipose tissues. The expression of MSTN mRNA in mesenteric fat increased in obese animals and decreased when these animals were subjected to swimming exercise. These results are consistent with previous report (Allen et al., 2008) demonstrating the increase of MSTN mRNA expression in fat in diet-induced obese mice. The actions of MSTN in adipose tissue and its metabolic effects are still controversial and MSTN has been reported to both promote and inhibit adipogenesis. In genetic models in which MSTN is blocked, adipose tissue is reduced and glucose metabolism is improved Lin et al., 2002; McPherron and Lee, 1997; McPherron and Lee, 2002; Tu et al., 2009 ). On the other hand, the increase of endogenous systemic MSTN by deletion of MSTN antagonist FSTL3 or by overexpression of MSTN propeptide resulted in reduced visceral fat and enhanced glucose tolerance and insulin sensitivity (Mukherjee et al., 2007; Zhao et al., 2005) . However, MSTN administration did not affect fat mass in adult animals (Stolz et al., 2008) . In vitro studies demonstrate that MSTN can directly modulate adipogenesis (Artaza et al., 2005; Feldman et al., 2006; Kim et al., 2001; Rebbapragada et al., 2003; Zimmers et al., 2002) . Guo et al. (2009) demonstrated that the blockade of MSTN signaling specifically in adipocytes had no effect on body composition, weight gain or glucose and insulin tolerance in mice, suggesting that increased insulin sensitivity and adipose tissue reduction observed in MSTN null mice is an indirect result of metabolic changes in skeletal muscle. However, it is possible that even modest amounts of locally expressed MSTN in adipose tissue, as showed here and by others (Allen et al., 2008) , affect energy metabolism functioning as paracrine and/or endocrine factors in adipose and other cell types, as other members of TGF␤ family do (McPherron, 2010) . It is well established that adipose tissue is considered an endocrine organ, rich in different cell types, including immune cells, and adpokines (Federico et al., 2010) . In fact, two recent reports (Lyons et al., 2010; Wilkes et al., 2009 ) demonstrate the close relationship between MSTN and the immune system. Lyons et al. (2010) demonstrated variable local expression of MSTN and pro-inflammatory cytokine production in spleen immune cells in response to high-fat diet intake in mice. In addition, Wilkes et al. (2009) observed the correlation of improvements in insulin sensitivity with decreased tumor necrosis factor (TNF)␣ production in adipose tissue and muscle in MSTN deficient high-fat fed mice. In these animals, treatment with recombinant MSTN increased circulating TNF␣ and insulin resistance.
We show for the first time that the expression of MSTN and ActRIIB mRNA varies in BAT in obesity and exercise. In addition, we observed that ActRIIB mRNA expression was significantly higher in BAT than in white gastrocnemuis muscle (∼10-fold higher). The expression of MSTN mRNA increased significantly in BAT of control and obese and insulin resistant rats after exercise. Interestingly, it was also observed that the expression of MSTN and ActRIIB varied reciprocally in BAT in sedentary and exercised control animals, suggesting an adaptive regulation between ligand and receptor. It has been shown that BAT has an important role in protection from diet-induced obesity, diabetes and insulin resistance and in the regulation of energy homeostasis through its unique function to dissipate energy in the form of heat in situations of energy surfeit or low environmental temperatures (Cannon and Nedergaard, 2004; Hamann et al., 1996; Redinger, 2009 ). In addition, it has been shown that exercise increases both BAT weight, as observed in the present study, and the expression of UCP-1 in BAT (Guerra et al., 2007; Oh et al., 2007) . Moreover, MSTN selectively inhibits BMP7 signaling (Rebbapragada et al., 2003) , whose expression is associated with increased brown adipocyte differentiation and energy expenditure (Tseng et al., 2008) . Taken together, these data suggest the involvement of BAT in energy homeostasis in exercise and a possible role of MSTN.
Previous studies have shown that MSTN may signal through intracellular insulin signaling pathway and thus affect insulin sensitivity in muscle. In muscle and adipose tissue from MSTN null mice and transgenic mice overexpressing MSTN propeptide, insulin signaling was increased by higher level of Akt phosphorilation Tu et al., 2009; Zhao et al., 2005) . In addition, it was demonstrated that upregulation of genes involved in glucose metabolism and activation of AMP-activated protein kinase (AMPK) by MSTN may be involved in glucose uptake and metabolism in muscle (Chen et al., 2010) . Interestingly, it has been shown that AMPK is also involved in BAT differentiation and glucose uptake in BAT (Hutchinson et al., 2005; Vila-Bedmar et al., 2010) .
The expression of MSTN and ActRIIB mRNA in grastrocnemius muscle of sedentary diet-induced obese animals was not different from sedentary control animals. However, it has been observed increase of MSTN mRNA in skeletal muscle of genetically obese (ob/ob) mice and obese and insulin resistant humans (Allen et al., 2008; Hittel et al., 2009 ). Other studies have demonstrated the decrease of MSTN expression in muscle of obese humans after weight loss induced by bariatric surgery (Milan et al., 2004; Park et al., 2006) . Different species and obesity models may explain the differences observed among the studies (Dilger et al., 2010) . Regarding post-exercise changes, muscle MSTN mRNA decreased in control animals. This result confirms previous studies and suggests the modulation of muscle MSTN mRNA by training in non-obese animals (Matsakas et al., 2006; Matsakas et al., 2005) and in humans (Hittel et al., 2010; Konopka et al., 2010) . We did not observe postexercise changes in muscle MSTN mRNA in diet-induced obese animals, in spite of the decrease in body weight. It is possible that the association between exercise and myostatin expression is independent of total body mass and involves other disarranged metabolic factors and adaptation present in obesity.
In conclusion, the results demonstrate that the expression of MSTN and ActRIIB mRNA changes in both adipose tissues and skeletal muscle in diet-induced obese and exercised rats and suggest the participation of MSTN in energy homeostasis. Further investigations are needed to better elucidate the metabolic functions of MSTN in whole body energy metabolism. 
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